Cargando…

Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes

In patients with autoimmune diabetes no significant differences were observed in glucose control, expressed as time in range evaluated by continuous glucose monitoring comparing the 3 days after Sars-Cov2 vaccine with the 14 days preceding the vaccine.

Detalles Bibliográficos
Autores principales:	D'Onofrio, Luca, Coraggio, Lucia, Zurru, Annalisa, Carlone, Angela, Mignogna, Carmen, Moretti, Chiara, Maddaloni, Ernesto, Buzzetti, Raffaella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383474/ https://www.ncbi.nlm.nih.gov/pubmed/34450248 http://dx.doi.org/10.1016/j.diabres.2021.109022

Ejemplares similares

Effects of the COVID‐19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study
por: D'Onofrio, Luca, et al.
Publicado: (2021)

Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications
por: D’Onofrio, Luca, et al.
Publicado: (2023)

Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis
por: Maddaloni, Ernesto, et al.
Publicado: (2021)

The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism
por: Mahrooz, Abdolkarim, et al.
Publicado: (2021)

Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I)
por: Maddaloni, Ernesto, et al.
Publicado: (2020)

Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA
por: Tiberti, Claudio, et al.
Publicado: (2022)

Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
por: Strollo, Rocky, et al.
Publicado: (2021)

Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement
por: Maddaloni, Ernesto, et al.
Publicado: (2015)

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)
por: Maddaloni, Ernesto, et al.
Publicado: (2020)

The Sodium–Glucose Co-Transporter-2 (SGLT2) Inhibitors Reduce Platelet Activation and Thrombus Formation by Lowering NOX2-Related Oxidative Stress: A Pilot Study
por: Pignatelli, Pasquale, et al.
Publicado: (2022)

An updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes
por: Maiorino, Maria Ida, et al.
Publicado: (2023)

Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study
por: Nusca, Annunziata, et al.
Publicado: (2015)

Minimizing Glucose Excursions (GEM) With Continuous Glucose Monitoring in Type 2 Diabetes: A Randomized Clinical Trial
por: Cox, Daniel J, et al.
Publicado: (2020)

Obesity, Autoimmunity, and Double Diabetes in Youth
por: Pozzilli, Paolo, et al.
Publicado: (2011)

Real-Time Sharing and Following of Continuous Glucose Monitoring Data in Youth
por: Welsh, John B., et al.
Publicado: (2019)

The Utility and Safety of a Continuous Glucose Monitoring System (CGMS) in Asphyxiated Neonates during Therapeutic Hypothermia
por: Giordano, Lucia, et al.
Publicado: (2023)

Performance of the Dexcom G6 Continuous Glucose Monitoring System in Pregnant Women with Diabetes
por: Castorino, Kristin, et al.
Publicado: (2020)

Proof-of-concept Application of Continuous Glucose Monitoring Data Analytics to Identify Diabetes Glucotypes
por: Steenkamp, Devin W, et al.
Publicado: (2023)

Steroid-Refractory Insulin Autoimmune Syndrome Treated With Rituximab and Continuous Glucose Monitoring
por: Batra, Chandar M, et al.
Publicado: (2021)

Comparison Between Continuous Versus Flash Glucose Monitoring in Children, Adolescents, and Young Adults with Type 1 Diabetes: An 8-Week Prospective Randomized Trial
por: Messaaoui, Anissa, et al.
Publicado: (2022)

Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study
por: Dorcely, Brenda, et al.
Publicado: (2022)

Continuous glucose monitoring
por: Pandit, Kaushik
Publicado: (2012)

β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults
por: Cernea, Simona, et al.
Publicado: (2009)

Performance of the Intermittently Scanned Continuous Glucose Monitoring (isCGM) System during a High Oral Glucose Challenge in Adults with Type 1 Diabetes—A Prospective Secondary Outcome Analysis
por: Moser, Othmar, et al.
Publicado: (2021)

Daytime Glycemic Variability and Frailty in Older Patients with Diabetes: a Pilot Study Using Continuous Glucose Monitoring
por: Chung, Seung Min, et al.
Publicado: (2021)

Glucose metabolism in cardiovascular surgery
por: Lazzeri, C, et al.
Publicado: (2010)

Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles
por: Tweden, Katherine S., et al.
Publicado: (2020)

Evaluation of a Fourth-Generation Subcutaneous Real-Time Continuous Glucose Monitor (CGM) in Individuals With Diabetes on Peritoneal Dialysis
por: Ng, Jack K.C., et al.
Publicado: (2023)

A caveolin-1 dependent glucose-6-phosphatase trafficking contributes to hepatic glucose production
por: Gautier-Stein, Amandine, et al.
Publicado: (2023)

Human continuous glucose monitors for measurement of glucose in dairy cows
por: Byrd, M.K.H., et al.
Publicado: (2021)

Continuous Glucose Monitoring in the Hospital
por: Perez-Guzman, M. Citlalli, et al.
Publicado: (2021)

Comparison of Serum PCSK9 Levels in Subjects with Normoglycemia, Impaired Fasting Glucose, and Impaired Glucose Tolerance
por: Han, Eugene, et al.
Publicado: (2020)

Cognitive glucose sensitivity—proposing a link between cognitive performance and reliance on external glucose uptake
por: Neukirchen, Tobias, et al.
Publicado: (2022)

Glucose metabolic reprogramming in autoimmune diseases
por: Jeong, Hoim, et al.
Publicado: (2023)

Hypoglycemic Event Frequency and the Effect of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections
por: Riddlesworth, Tonya, et al.
Publicado: (2017)

Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry Study
por: Deiss, Dorothee, et al.
Publicado: (2020)

Remote Application and Use of Real-Time Continuous Glucose Monitoring by Adults with Type 2 Diabetes in a Virtual Diabetes Clinic
por: Bergenstal, Richard M., et al.
Publicado: (2021)

Erroneous glucose recordings while using mutant variant of quinoprotein glucose dehydrogenase glucometer in a child with galactosemia
por: Mathew, Vivek, et al.
Publicado: (2013)

Comprehensive Review on Wearable Sweat-Glucose Sensors for Continuous Glucose Monitoring
por: Zafar, Hima, et al.
Publicado: (2022)

Glycemic Improvement Using Continuous Glucose Monitoring by Baseline Time in Range: Subgroup Analyses from the DIAMOND Type 1 Diabetes Study
por: Calhoun, Peter, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m1iinm0mp83hdo4kriplc6hf0p